{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:29:25Z","timestamp":1758403765183},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,9]]},"DOI":"10.7759\/cureus.33545","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T17:43:37Z","timestamp":1673286217000},"source":"Crossref","is-referenced-by-count":1,"title":["Masked Polycythemia Vera and Iron Deficiency in a Fertile-Age Woman"],"prefix":"10.7759","author":[{"given":"Lu\u00eds R","family":"Almeida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diogo","family":"Faustino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Gameiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Salvado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3906\/sag-1907-67","article-title":"Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency","volume":"49","author":"Alada\u011f E","year":"2019","unstructured":"Alada\u011f E, Aksu S, Demiro\u011flu H, et al.. Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency. Turk J Med Sci. 2019, 49:1560-3. 10.3906\/sag-1907-67","journal-title":"Turk J Med Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber DA","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al.. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016, 127:2391-405. 10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15648","article-title":"A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology guideline","volume":"184","author":"McMullin MF","year":"2019","unstructured":"McMullin MF, Harrison CN, Ali S, et al.. A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology guideline. Br J Haematol. 2019, 184:176-91. 10.1111\/bjh.15648","journal-title":"Br J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0054-y","article-title":"The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion","volume":"8","author":"Barbui T","year":"2018","unstructured":"Barbui T, Thiele J, Gisslinger H, et al.. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J. 2018, 8:15. 10.1038\/s41408-018-0054-y","journal-title":"Blood Cancer J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7150\/jca.27414","article-title":"Detection of exon 12 and 14 mutations in Janus kinase 2 gene including a novel mutant in V617F negative polycythemia vera patients from Pakistan","volume":"9","author":"Akram AM","year":"2018","unstructured":"Akram AM, Kausar H, Chaudhary A, et al.. Detection of exon 12 and 14 mutations in Janus kinase 2 gene including a novel mutant in V617F negative polycythemia vera patients from Pakistan. J Cancer. 2018, 9:4341-5. 10.7150\/jca.27414","journal-title":"J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0207-9","article-title":"Dysregulated iron metabolism in polycythemia vera: etiology and consequences","volume":"32","author":"Ginzburg YZ","year":"2018","unstructured":"Ginzburg YZ, Feola M, Zimran E, Varkonyi J, Ganz T, Hoffman R. Dysregulated iron metabolism in polycythemia vera: etiology and consequences. Leukemia. 2018, 32:2105-16. 10.1038\/s41375-018-0207-9","journal-title":"Leukemia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2016.08.007","article-title":"Polycythemia vera masked due to severe iron deficiency anemia","volume":"11","author":"Kambali S","year":"2018","unstructured":"Kambali S, Taj A. Polycythemia vera masked due to severe iron deficiency anemia. Hematol Oncol Stem Cell Ther. 2018, 11:38-40. 10.1016\/j.hemonc.2016.08.007","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.163","article-title":"Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study","volume":"27","author":"Tefferi A","year":"2013","unstructured":"Tefferi A, Rumi E, Finazzi G, et al.. Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. Leukemia. 2013, 27:1874-81. 10.1038\/leu.2013.163","journal-title":"Leukemia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23585","article-title":"Masked polycythemia vera (mPV): results of an international study","volume":"89","author":"Barbui T","year":"2014","unstructured":"Barbui T, Thiele J, Gisslinger H, et al.. Masked polycythemia vera (mPV): results of an international study. Am J Hematol. 2014, 89:52-4. 10.1002\/ajh.23585","journal-title":"Am J Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13080","article-title":"A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera","volume":"167","author":"Lussana F","year":"2014","unstructured":"Lussana F, Carobbio A, Randi ML, et al.. A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera. Br J Haematol. 2014, 167:541-6. 10.1111\/bjh.13080","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165805","article-title":"New perspectives on polycythemia vera: from diagnosis to therapy","volume":"21","author":"Iurlo A","year":"2020","unstructured":"Iurlo A, Cattaneo D, Bucelli C, Baldini L. New perspectives on polycythemia vera: from diagnosis to therapy. Int J Mol Sci. 2020, 21:5805. 10.3390\/ijms21165805","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01401-3","article-title":"Polycythemia vera: historical oversights, diagnostic details, and therapeutic views","volume":"35","author":"Tefferi A","year":"2021","unstructured":"Tefferi A, Vannucchi AM, Barbui T. Polycythemia vera: historical oversights, diagnostic details, and therapeutic views. Leukemia. 2021, 35:3339-51. 10.1038\/s41375-021-01401-3","journal-title":"Leukemia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12552","article-title":"Masked polycythaemia vera: presenting features, response to treatment and clinical outcomes","volume":"96","author":"Alvarez-Larr\u00e1n A","year":"2016","unstructured":"Alvarez-Larr\u00e1n A, Angona A, Ancochea A, et al.. Masked polycythaemia vera: presenting features, response to treatment and clinical outcomes. Eur J Haematol. 2016, 96:83-9. 10.1111\/ejh.12552","journal-title":"Eur J Haematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012743","article-title":"A randomized phase 3 trial of interferon-\u03b1 vs hydroxyurea in polycythemia vera and essential thrombocythemia","volume":"139","author":"Mascarenhas J","year":"2022","unstructured":"Mascarenhas J, Kosiorek HE, Prchal JT, et al.. A randomized phase 3 trial of interferon-\u03b1 vs hydroxyurea in polycythemia vera and essential thrombocythemia. Blood. 2022, 139:2931-41. 10.1182\/blood.2021012743","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-022-03336-6","article-title":"Treatment options and pregnancy management for patients with PV and ET","volume":"115","author":"Edahiro Y","year":"2022","unstructured":"Edahiro Y. Treatment options and pregnancy management for patients with PV and ET. Int J Hematol. 2022, 115:659-71. 10.1007\/s12185-022-03336-6","journal-title":"Int J Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/129368-masked-polycythemia-vera-and-iron-deficiency-in-a-fertile-age-woman","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:15Z","timestamp":1707508515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/129368-masked-polycythemia-vera-and-iron-deficiency-in-a-fertile-age-woman"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.33545","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,9]]}}}